Christopher A. Barker

14.6k total citations · 2 hit papers
131 papers, 4.0k citations indexed

About

Christopher A. Barker is a scholar working on Oncology, Epidemiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Christopher A. Barker has authored 131 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 74 papers in Oncology, 37 papers in Epidemiology and 29 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Christopher A. Barker's work include Nonmelanoma Skin Cancer Studies (32 papers), Cutaneous Melanoma Detection and Management (24 papers) and Ocular Oncology and Treatments (21 papers). Christopher A. Barker is often cited by papers focused on Nonmelanoma Skin Cancer Studies (32 papers), Cutaneous Melanoma Detection and Management (24 papers) and Ocular Oncology and Treatments (21 papers). Christopher A. Barker collaborates with scholars based in United States, Spain and Canada. Christopher A. Barker's co-authors include Michael A. Postow, Kathryn Beal, Jedd D. Wolchok, Yoshiya Yamada, Kishwer S. Nehal, Shoko Mori, Anthony Rossi, Nancy Y. Lee, Miguel Córdova and Suzanne L. Wolden and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer.

In The Last Decade

Christopher A. Barker

122 papers receiving 4.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Stereotactic Radiosurgery for Melanoma Brain Metastases in Patients Receiving Ipilimumab: Safety Profile and Efficacy of Combined Treatment

2015 306 citations Jedd D. Wolchok, Christopher A. Barker et al. International Journal of Radiation Oncology*Biology*Physics profile →
Basal cell carcinoma

2018 297 citations Christopher A. Barker et al. Journal of the American Academy of Dermatology profile →

Peers

Countries citing papers authored by Christopher A. Barker

Since Specialization

Citations

This map shows the geographic impact of Christopher A. Barker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher A. Barker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher A. Barker more than expected).

Fields of papers citing papers by Christopher A. Barker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher A. Barker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher A. Barker. The network helps show where Christopher A. Barker may publish in the future.

Co-authorship network of co-authors of Christopher A. Barker

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher A. Barker. A scholar is included among the top collaborators of Christopher A. Barker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher A. Barker. Christopher A. Barker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Gantry-based pencil beam scanning proton therapy for uveal melanoma: IMPT versus proton arc therapy 2025 ·Radiation Oncology ·Hang Qi, (unknown), Sheng Huang, (unknown), Francis T. S. Yu, Qing Chen, Yunjie Yang, Minglei Kang, Huifang Zhai, M. A. Vermeulen, (unknown), Peter J. Park, Xuanfeng Ding, Jun Zhou, David H. Abramson, Jasmine H. Francis, (unknown), Christopher A. Barker, Haibo Lin	0
2	A Phase II Randomized Study of Proton vs. Intensity-Modulated Radiation Therapy in the Treatment of Unilateral Head and Neck Cancer 2025 ·International Journal of Radiation OncologyBiologyPhysics ·(unknown), Noah S. Kalman, (unknown), (unknown), (unknown), (unknown), Yang Yu, (unknown), Sean M. McBride, Nadeem Riaz, (unknown), A. Shamseddine, Kaveh Zakeri, Jung Julie Kang, (unknown), Yu Wu, Alan L. Ho, (unknown), Paul B. Romesser, Christopher A. Barker	0
3	ASO Author Reflections: The Role of Postoperative Radiation Therapy Following Wide Excision of Neurotropic Melanoma of the Head and Neck: Now and into the Future 2024 ·Annals of Surgical Oncology ·Mark B. Pinkham, Alan Herschtal, Hong Ai, (unknown), Richard A. Scolyer, (unknown), (unknown), Jenny Nobes, Christopher A. Barker, B. Ashleigh Guadagnolo, Gerald B. Fogarty, Bryan Burmeister, (unknown)	1
4	Phase II, Single-Arm Trial of Induction and Concurrent Vismodegib With Curative-Intent Radiation Therapy for Locally Advanced, Unresectable Basal Cell Carcinoma 2024 ·Journal of Clinical Oncology ·Christopher A. Barker, Suzanne M. Dufault, Sarah T. Arron, Alan L. Ho, Alain P. Algazi, Lara Dunn, (unknown), (unknown), (unknown), P. Daniel Knott, Sue S. Yom	9
5	Brain radiotherapy, tremelimumab-mediated CTLA-4-directed blockade +/− trastuzumab in patients with breast cancer brain metastases 2022 ·npj Breast Cancer ·David B. Page, Kathryn Beal, Stefanie N. Linch, Kateri J. Spinelli, (unknown), Darragh Halpenny, Shanu Modi, Sujata Patil, Robert J. Young, Thomas Kaley, Taha Merghoub, David Redmond, Phillip Wong, Christopher A. Barker, Adi Diab, Larry Norton, Heather L. McArthur	25
6	Pilot Trial of Arginine Deprivation Plus Nivolumab and Ipilimumab in Patients with Metastatic Uveal Melanoma 2022 ·Cancers ·Lukas Kraehenbuehl, Aliya Holland, (unknown), (unknown), Levi Mangarin, (unknown), Amanda Johnston, John S. Bomalaski, Joseph P. Erinjeri, Christopher A. Barker, Jasmine H. Francis, Jedd D. Wolchok, Taha Merghoub, Alexander N. Shoushtari	15
7	¹⁸F-FDG PET/CT for Posttreatment Surveillance Imaging of Patients with Stage III Merkel Cell Carcinoma 2021 ·Journal of Nuclear Medicine ·Sonia Mahajan, Christopher A. Barker, Audrey Mauguen, Sandra P. D’Angelo, Randy Yeh, Neeta Pandit‐Taskar	2
8	Clinical Review of Proton Therapy in the Treatment of Unilateral Head and Neck Cancers 2021 ·International Journal of Particle Therapy ·Robert H. Press, Richard L. Bakst, Sonam Sharma, Rafi Kabarriti, Madhur Garg, Brian Yeh, (unknown), Shaakir Hasan, J. Isabelle Choi, Christopher A. Barker, Arpit M. Chhabra, Charles B. Simone, Nancy Y. Lee	4
9	Quantitation of Urinary Acylcarnitines by DMS-MS/MS Uncovers the Effects of Total Body Irradiation in Cancer Patients 2020 ·Journal of the American Society for Mass Spectrometry ·Nicholas B. Vera, Stephen L. Coy, Evagelia C. Laiakis, Albert J. Fornace, Michelle Clasquin, Christopher A. Barker, Jeffrey A. Pfefferkorn, Paul Vouros	5
10	Primary tumor volume as a predictor of distant metastases and survival in patients with sinonasal mucosal melanoma 2020 ·Head & Neck ·(unknown), Shivangi Lohia, Christopher A. Barker, Jennifer R. Cracchiolo, Ian Ganly, Snehal G. Patel, Benjamin R. Roman, Jatin P. Shah, Alexander N. Shoushtari, Viviane Tabar, Akash Shah, Marc A. Cohen	5
11	Organ preservation for patients with anterior mucosal squamous cell carcinoma of the nasal cavity: Rhinectomy‐free survival in those refusing surgery 2019 ·Head & Neck ·(unknown), Yao Yu, Marlena McGill, Christopher A. Barker, Sean M. McBride, Ian Ganly, Jennifer R. Cracchiolo, Lara Dunn, Nora Katabi, Kevin Sine, Dennis Mah, Anna Lee, Nancy Y. Lee, Marc A. Cohen	8
12	Restaging [18F] fludeoxyglucose positron emission tomography/computed tomography scan in recurrent cutaneous squamous cell carcinoma: Diagnostic performance and prognostic significance 2019 ·Journal of the American Academy of Dermatology ·Sonia Mahajan, Christopher A. Barker, Audrey Mauguen, Bhuvanesh Singh, Neeta Pandit‐Taskar	7
13	Regional Lymph Node Basin (RLNB) Relapse after Adjuvant Ipilimumab (Ipi) Anti-CTLA4 Immunotherapy in Stage III Melanoma: A Subgroup Analysis of a Randomized Placebo-Controlled Trial 2017 ·International Journal of Radiation OncologyBiologyPhysics ·Christopher A. Barker, (unknown), (unknown), Jonathan D. Schoenfeld, F. Stephen Hodi, Douglas B. Johnson, Jedd D. Wolchok	1
14	A single-arm, phase ii study assessing the efficacy of pembrolizumab (pembro) plus radiotherapy (RT) in metastatic triple negative breast cancer (mTNBC) 2017 ·Annals of Oncology ·Heather L. McArthur, Christopher A. Barker, Ayca Gucalp, (unknown), Yuetao Wen, (unknown), (unknown), (unknown), Brittany Arnold, (unknown), Allen S. Ho	13
15	Impact of source position on high-dose-rate skin surface applicator dosimetry 2016 ·Brachytherapy ·(unknown), Christopher A. Barker, Marco Zaider, Gil’ad N. Cohen	9
16	Survival of patients treated with radiation therapy for anaplastic astrocytoma 2014 ·Radiology and Oncology ·Christopher A. Barker, Maria Chang, Timothy A. Chan	8
17	Ipilimumab and whole brain radiation therapy for melanoma brain metastases 2014 ·Journal of Neuro-Oncology ·Naamit K. Gerber, Robert J. Young, Christopher A. Barker, Jedd D. Wolchok, Timothy A. Chan, Yoshiya Yamada, (unknown), Kathryn Beal	48
18	Concurrent Radiotherapy and Ipilimumab Immunotherapy for Patients with Melanoma 2013 ·Cancer Immunology Research ·Christopher A. Barker, Michael A. Postow, Shaheer Khan, Kathryn Beal, Preeti K. Parhar, Yoshiya Yamada, Nancy Y. Lee, Jedd D. Wolchok	127
19	Hyperfractionated Low-Dose (21 Gy) Radiotherapy for Cranial Skeletal Metastases in Patients With High-Risk Neuroblastoma 2009 ·International Journal of Radiation OncologyBiologyPhysics ·Brian H. Kushner, Nai‐Kong V. Cheung, Christopher A. Barker, Kim Kramer, Shakeel Modak, (unknown), Suzanne L. Wolden	9
20	Brain‐sparing radiotherapy for neuroblastoma skull metastases 2007 ·Pediatric Blood & Cancer ·Suzanne L. Wolden, Christopher A. Barker, Brian H. Kushner, (unknown), (unknown), Kim Kramer, Shakeel Modak, Nai‐Kong V. Cheung	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact